|
Item
|
Treatmenta
|
SEM
|
Contrastb
|
|---|
|
Control
|
PBLC-L
|
PBLC-H
| |
1
|
2
|
3
|
|---|
|
Ala
|
60
|
61
|
61
|
0.6
|
0.30
|
0.45
|
0.20
|
|
Val
|
118
|
120
|
118
|
2.4
|
0.96
|
0.50
|
0.70
|
|
Leu
|
133
|
137
|
137
|
1.8
|
0.14
|
0.49
|
0.11
|
|
Ile
|
133
|
136
|
136
|
1.3
|
0.19
|
0.46
|
0.14
|
|
Phe
|
223
|
227
|
228
|
2.5
|
0.17
|
0.63
|
0.15
|
|
Met
|
154
|
154
|
154
|
0.6
|
0.75
|
0.92
|
0.82
|
|
Proc
|
103
|
105#
|
105
|
1.0
|
0.12
|
0.32
|
0.072
|
|
Glyc
|
60
|
66#
|
59
|
2.5
|
0.85
|
0.058
|
0.41
|
|
Ser
|
82
|
82
|
84
|
1.7
|
0.42
|
0.72
|
0.60
|
|
Cys
|
200
|
200
|
201
|
0.7
|
0.13
|
0.39
|
0.37
|
|
Thr
|
113
|
115
|
115
|
1.2
|
0.30
|
0.50
|
0.22
|
|
Tyr
|
289
|
298
|
290
|
4.3
|
0.84
|
0.11
|
0.32
|
|
Asp+Asnc
|
121
|
125#
|
128*
|
1.4
|
0.005
|
0.79
|
0.009
|
|
Glu + Glnc
|
160
|
174*
|
174*
|
4.5
|
0.041
|
0.22
|
0.020
|
|
Lysc
|
147
|
148
|
152*
|
1.5
|
0.054
|
0.50
|
0.17
|
|
His
|
171
|
171
|
168
|
1.9
|
0.31
|
0.62
|
0.52
|
|
Arg
|
345
|
353
|
341
|
11.9
|
0.81
|
0.41
|
0.83
|
|
Total
|
2611
|
2672
|
2651
|
32.0
|
0.42
|
0.52
|
0.68
|
- SEM standard error of mean
- aControl: without PBLC; PBLC-L: lower dose (80 mg/d) of PBLC; and PBLC-H: higher dose (160 mg/d) of PBLC
- bContrast: 1 = linear effect; 2 = quadratic effect; and 3 = Control versus both PBLC groups
- cSince CP intake could be a factor affecting serum amino acid concentrations, CP intake was used as covariate for amino acids those resulted in P < 0.10, and the statistical results are provided in the text
- #/*Mean values differ compared with the control at P < 0.10/0.05
